Health Phase 1 Trial Shows Promising Safety and Extended Half-Life for Modified HIV-1 Monoclonal Antibody PGDM1400LSBy Stanley SimalsJune 5, 2025 Health 3 Mins Read Researchers have reported positive phase 1 trial results for a modified monoclonal antibody aimed at preventing HIV-1 infection. This development…
